Evidence map›Paper›PMID 37224690›Full record

Trial reportAtencion primaria2023

[ADHEFAP: Clinical trial to evaluate an educational-behavioral telephone intervention by the primary care pharmacist to improve therapeutic adherence].

Blanca Basagoiti Carreño, Ana Díez Alcántara, Belén María Escudero Vilaplana, Genma María Silva Riádigos, Beatriz Benítez García, Virginia Greciano, investigadores colaboradores

Open access · goldAbstract readRandomized Controlled TrialEnglish Abstract
In one paragraph

Trial report in Atencion primaria, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Blanca Basagoiti CarreñoServicio de Farmacia de Atención Primaria, Dirección Asistencial Noroeste, Gerencia Asistencial de Atención Primaria de Madrid, Majadahonda, Madrid, España. Electronic address: blanca.basagoiti@salud.madrid.org.
Ana Díez AlcántaraServicio de Farmacia de Atención Primaria, Dirección Asistencial Noroeste, Gerencia Asistencial de Atención Primaria de Madrid, Majadahonda, Madrid, España.
Belén María Escudero VilaplanaServicio de Farmacia de Atención Primaria, Dirección Asistencial Oeste, Gerencia Asistencial de Atención Primaria de Madrid, Móstoles, Madrid, España.
Genma María Silva RiádigosServicio de Farmacia de Atención Primaria, Dirección Asistencial Oeste, Gerencia Asistencial de Atención Primaria de Madrid, Móstoles, Madrid, España.
Beatriz Benítez GarcíaServicio de Farmacia de Atención Primaria, Dirección Asistencial Este, Gerencia Asistencial de Atención Primaria de Madrid, Alcalá de Henares, Madrid, España.
Virginia GrecianoServicio de Farmacia de Atención Primaria, Dirección Asistencial Este, Gerencia Asistencial de Atención Primaria de Madrid, Alcalá de Henares, Madrid, España.
investigadores colaboradores
Madrid Health Service · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEvaluate the improvement in therapeutic adherence of an intervention based on telephone monitoring by the primary care pharmacist.

designRandomized open controlled trial. LOCATION: This study was carried out in 2021 by a multidisciplinary team working with health professionals of thirteen health centers belonging to four health districts in Community of Madrid, Spain.

participantsThese were patients (60-74 years) with polipharmacy classified as non-adherent according to the Morisky-Green test. Two hundred and twenty-four patients were originally enrolled, 87 of them were non-adherents. Of these, 15 were lost and 72 were finally randomized. Seventy-one patients completed the study (33 intervention group and 38 control group).

interventionsPatients randomized to the intervention arm were included in a follow-up telephone program consisting of an interview at months 1, 2, and 3 to improve adherence. The Morisky-Green test was repeated at month 4 to assess improvement. In the control group this test was only performed at month 4. MAIN MEASUREMENTS: Adherence measured by Morisky-Green at baseline and at 4th month.

resultsThe 72.7% of patients in the intervention group became adherent while only 34.2% did in the control arm, being the difference 38.5% (95% CI: 17.1-59.9), statistically significant (P=.001).

conclusionsAfter a follow-up educational-behavioral telephone intervention in non-adherent patients by the primary care pharmacist, therapeutic adherence was improved statistically significantly in the intervention group compared with the control group.

Indexed as

PharmacistsTreatment Adherence and ComplianceHumansMedication AdherencePrimary Health CareSpainTelephoneAdherenceAdherenciaAtención primariaClinical trialEducación para la saludEnsayo clínicoFarmacéuticoHealth educationPharmacistPrimary care

Identifiers

PMID37224690
PMCPMC10403683
OpenAlexW4377261673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.